IPO mania vs risk control: warnings from pump-and-dump tips and listing discipline across Indian markets

IPO mania meets risk control as online chatter flags pump-and-dump traps and listing discipline in Indian markets. The warnings hit fast: don't trust tips, wait for proven signals, and be ready to dodge IPO hype.

Here are the standout cautions making the rounds:

• Cian Agro and Titan Biotech pump-and-dump tales warn why online tips mislead, with Manish Goyal linked to the Titan Biotech saga. “Never believe anyone online” is the lesson. ^[1]
• Pinelabs marketing chatter draws skepticism; critics say PR around Pinelabs can feel influencer-like and scammy. ^[3]
• Lenskart IPO risk is real: GMP has cooled, the deal carries a high P/E, and OFS pressure raises mispricing concerns as listing day moves loom. ^[5]
• Groww chatter reflects mixed nerves: some say gains could be minimal and fear IPO-driven moves. ^[2]

Another thread zooms in on mutual funds and SIPs:

• Stop your SIPs because some funds subscribe to IPOs and tilt portfolios toward highly pitched issues; diversify away from IPO-focused bets. ^[4]
• Consider value-oriented funds such as ICICI Value Discovery Fund, HSBC Value Fund, and DSP Value Fund as alternatives to IPO-heavy bets. ^[4]

Bottom line: in a market where IPO fever collides with mispricing risks, patience and diversification are the antidotes. Watch for fresh chatter and lean toward disciplined, value-focused choices. ^[4]

References